Literature DB >> 9307203

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

S Störkel1, J N Eble, K Adlakha, M Amin, M L Blute, D G Bostwick, M Darson, B Delahunt, K Iczkowski.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9307203     DOI： 10.1002/(sici)1097-0142(19970901)80:5<987::aid-cncr24>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  157 in total

1.  Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability.

Authors:  Kathryn Farrand; Lydija Jovanovic; Brett Delahunt; Bryan McIver; Ian D Hay; Norman L Eberhardt; Stefan K G Grebe
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

2.  Premalignant lesions of the kidney share the same genetics changes as conventional renal cell carcinoma.

Authors:  S Pehlivan; M Koyuncuoglu; M Pehlivan; S Izzetoglu; Y Mater; M Cabuk; Z Kirkali
Journal:  World J Urol       Date:  2003-12-20       Impact factor: 4.226

3.  Molecular pathology of renal cell carcinoma.

Authors:  S Störkel
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

Review 4.  [Systemic treatment of renal cell carcinoma - recent update].

Authors:  Birgit Grünberger
Journal:  Wien Med Wochenschr       Date:  2011-08

5.  Two different renal cell carcinomas and multiple angiomyolipomas in a patient with tuberous sclerosis.

Authors:  Sung Gu Kang; Young Hwii Ko; Seok Ho Kang; Jin Kim; Chul Hwan Kim; Hong Seok Park; Du Geon Moon; Jeong Gu Lee; Je Jong Kim; Jun Cheon
Journal:  Korean J Urol       Date:  2010-10-21

6.  The somatic genomic landscape of chromophobe renal cell carcinoma.

Authors:  Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton
Journal:  Cancer Cell       Date:  2014-08-21       Impact factor: 31.743

Review 7.  Radiologic-pathologic correlations of intratumoral tissue components in the most common solid and cystic renal tumors. Pictorial review.

Authors:  Emilio Quaia; Rossana Bussani; Maria Cova; Roberto Pozzi Mucelli
Journal:  Eur Radiol       Date:  2005-03-08       Impact factor: 5.315

8.  Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis.

Authors:  Toshiaki Kinouchi; Junichi Sakamoto; Taiji Tsukamoto; Hideyuki Akaza; Yoshinobu Kubota; Seiichiro Ozono; Hiroshi Kanetake; Tetsuo Taguchi; Toshihiko Kotake
Journal:  J Cancer Res Clin Oncol       Date:  2006-04-04       Impact factor: 4.553

9.  Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.

Authors:  Won K Han; Anwar Alinani; Chin-Lee Wu; Dror Michaelson; Massimo Loda; Francis J McGovern; Ravi Thadhani; Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2005-03-02       Impact factor: 10.121

10.  Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome.

Authors:  U Zimmermann; C Woenckhaus; S Pietschmann; H Junker; S Maile; K Schultz; C Protzel; J Giebel
Journal:  Virchows Arch       Date:  2004-08-26       Impact factor: 4.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.